• Australian (ASX) Stock Market Forum

Hello and welcome to Aussie Stock Forums!

To gain full access you must register. Registration is free and takes only a few seconds to complete.

Already a member? Log in here.

CSL - CSL Limited

Discussion in 'Stocks 0-H' started by kaisong, Dec 16, 2004.

  1. galumay

    galumay learner

    Posts:
    2,177
    Likes Received:
    766
    Joined:
    Sep 17, 2011
    Revenue growing at 9% and a p/e of 50. Fine, nothing to see here. Even the blue chips are stonks these days. Maths is dead. All aboard, the rocket departs shortly!!
     
  2. Dona Ferentes

    Dona Ferentes

    Posts:
    1,161
    Likes Received:
    1,195
    Joined:
    Jan 11, 2016
  3. Knobby22

    Knobby22 Mmmmmm 2nd breakfast

    Posts:
    5,891
    Likes Received:
    1,293
    Joined:
    Oct 13, 2004
    11% profit growth per half in first half. Second half has been advised as being in the range of 8- 16% but knowing CSL will be closer to 16%.
    Also phase 3 drug trial for a drug to stop recurring heart attacks is taking place with thousands of patients over many hospitals. Predicted revenue/profit increase to CSL if trial succeeds 45%. Nothing to sneeze at. I think this is the reason the PE has got a bit stretched.
    Not unrealistic. When you value shares you have to factor in growth.

    Dividends are in US$ so translating it to Australian currencies the dividend increase is actually greater than first appears.

    From a fundamental investor viewpoint I am happy to hold. It is in my view one of Australia's only true blue chip companies. You look at the top 10 and they are all duds, Telstra, the Banks etc.

    It would be difficult for me to sell anyway as it is a 300 bagger and I bought them in my name years ago when I first stated investing (doing a course on corporate finance as an adjunct to my engineering degree where I valued CSL and decided to buy) and would have to pay too much tax.
     
  4. Dona Ferentes

    Dona Ferentes

    Posts:
    1,161
    Likes Received:
    1,195
    Joined:
    Jan 11, 2016
    The medicines he is referring include immunoglobulin therapies, which are used to treat immunodeficiencies and have been the biggest driver of CSL’s growth. The company also produces treatments for blood-related disorders, such as haemophilia, and influenza vaccines. And there is more to come, with CSL spending about $1bn a year on drug trials to build its pipeline of future blockbusters.

    - my younger brother has received 55 IVIG* treatments in the last half-decade, one a month. The specialists are upping it from one a month to one a fortnight, three hours in the chair each time. $5,000 a pop of CSL's Privigen. (thanks taxpayers/ Medicare, btw).

    This has come about as they have seen its the only thing that holds off his undiagnosed condition. Since recently identifying a genetic marker for MND, but also another as yet unascribed, the sophistication of the therapies increase as the understanding does..

    *intravenous immunoglobulin
     
    Knobby22 likes this.
  5. Dona Ferentes

    Dona Ferentes

    Posts:
    1,161
    Likes Received:
    1,195
    Joined:
    Jan 11, 2016
    correction
    he gets 40g/400ml each time = A$1800, on the National Product List of the National Blood Agreement, funded 63% by the Commonwealth and 37% by the states and territories.
     
  6. Dona Ferentes

    Dona Ferentes

    Posts:
    1,161
    Likes Received:
    1,195
    Joined:
    Jan 11, 2016
    and then
    and an interesting bit of news last Wednesday
    from an Alan Kohler column. Of course it's not binary; as #2 and 3 (dual listed BHP is Australia's biggest listed entity) you're allowed to own both. Blue chips are there because of their track records. Didn't fall from outer space.

    And, good point about tax realities. It's not all about the buy side; reasons to sell are as complex and often not as discernable. Takes both sides to make a market.
     
    Knobby22 likes this.
  7. Knobby22

    Knobby22 Mmmmmm 2nd breakfast

    Posts:
    5,891
    Likes Received:
    1,293
    Joined:
    Oct 13, 2004
    Yes, however,

    In 5 years time CSL will still be priced at 30 times earnings while CBA will still be at a much lower ratio probably 18.

    The CSL capitilisation however will be double CBA. The power of compound growth is why investors are willing to pay more.

    Sure we have BHP up there, A true blue chip though very cyclical. A survivor.

    The banks, which are under subtle attack by companies like Apple and Google as well as the fintechs.

    Wesfarmers- a conglomerate, so will pass that as a blue chip.

    Telstra, Woolworths. Nuff said.

    We don't have much that is world competing, dynamic, growing strongly.
    We need, as a nation, some world leaders.
     
    sptrawler and qldfrog like this.
  8. Dona Ferentes

    Dona Ferentes

    Posts:
    1,161
    Likes Received:
    1,195
    Joined:
    Jan 11, 2016
    CSL shares closed at $338.68, retreating from an intra-day high of $342.75 and, at one point, 8.05 per cent of the benchmark index, unseating Commonwealth Bank at 8.03 per cent and 5.9 per cent for BHP Billiton. The miner boasts the largest overall valuation of any listed Australian company, but its shares are dual listed on the London Stock Exchange.
     
    Trav. and Knobby22 like this.
  9. sptrawler

    sptrawler

    Posts:
    14,071
    Likes Received:
    4,842
    Joined:
    Jul 3, 2009
    Thanks for that Dona, I bought 2000 at $27, after the GFC, sold them at $30something, when I was made redundant. The story of my life.lol
     
    Trav. likes this.
  10. Dona Ferentes

    Dona Ferentes

    Posts:
    1,161
    Likes Received:
    1,195
    Joined:
    Jan 11, 2016
    While CSL's Seqirus division manufactures flu vaccines, it has not been directly engaged in the search for a coronavirus vaccine and the conditions are quite different.

    Instead, the company has donated some of its proprietary technology to the team at the University of Queensland working on a COVID-19 vaccine.
     
    Trav. and Knobby22 like this.
  11. Tumbarumba

    Tumbarumba

    Posts:
    62
    Likes Received:
    25
    Joined:
    Oct 24, 2014
    CSL is getting more involved now.Latest press release states,
    Coronavirus is quite different to influenza virus so is not a core area of focus for CSL. On saying that, given the mounting public health issue this has become, we are investigating what adjacencies in expertise, technologies and facilities we might contribute as a collaborator to the global effort.
    CSL already has 30% of the flu vaccine market. SP oversold during recent market panic.
     
    Trav. and Dona Ferentes like this.
Loading...
Similar Threads - CSL CSL Limited
  1. paulahb
    Replies:
    1
    Views:
    3,119

Share This Page